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Abstract Urine samples from 20 male volunteers of Euro-
pean Caucasian origin were stored at 4°C over a 4-month
period in order to compare the identification potential of
nuclear DNA (nDNA) and mitochondrial DNA (mtDNA)
markers. The amount of nDNA recovered from urines dra-
matically declined over time. Consequently, nDNA like-
lihood ratios (LRs) greater than 1,000 were obtained for
100, 70 and 55% of the urines analysed after 6, 60 and 120
days, respectively. For the mtDNA, HVI and HVII se-
quences were obtained for all samples tested, whatever the
period considered. Nevertheless, the highest mtDNA LR
of 435 was relatively low compared to its nDNA equiv-
alent. Indeed, LRs obtained with only three nDNA loci
could easily exceed this value and are quite easier to ob-
tain. Overall, the joint use of nDNA and mtDNA markers
enabled the 20 urine samples to be identified, even after
the 4-month period.
Keywords Doping control . Urine samples . Nuclear
DNA . Mitochondrial DNA . Evidence evaluation
Introduction
Genetic profiling can be used to identify biological material
found at a crime scene or to prove that no manipulation
of biological samples occurred in clinical, toxicological
or doping control tests [e.g. 1, 2]. Within this context, the
strength of a match between the genetic profile of a ques-
tioned sample and the genetic profile of the corresponding
person (the suspect) is generally evaluated with a likeli-
hood ratio (LR) [3]. The higher the LR, the more support
is given to the hypothesis that the sample originated from
the suspect rather than from another person unrelated to
the suspect.
LR values strongly depend on the genetic marker con-
sidered, and individual LRs obtained from independent
nuclear DNA (nDNA) loci can be multiplied. Consequent-
ly, the use of short tandem repeat (STR) multiplexes that
contain 10 (e.g. AmpFlSTR SGM Plus from Applied Bio-
systems, Rotkreuz, Switzerland) or 15 (e.g. PowerPlex 16
from Promega) unlinked nDNA markers generally allows
high LRs to be obtained. The mitochondrial genome is
maternally transmitted and lacks recombination [4]. The
genetic information recovered from this haploid genome
thus always corresponds to a single marker, whatever the
number of nucleotides or regions sequenced. LRs for mito-
chondrial DNA (mtDNA) are therefore generally much
lower than those for nDNA. Moreover, mtDNA markers
allow identification of a maternal lineage, whereas nDNA
markers enable individualization of a person. A major ad-
vantage of the mtDNA is that its number of copies in
mammalian cells may exceed 1,000 times the number of
nDNA copies [5]. MtDNA markers thus represent an al-
ternative to nDNA markers in analysing biological sam-
ples poor in nucleated cells and/or stored in bad conditions
[e.g. 6].
In some contentious situations, the identity of urine
samples involved in doping control analysis has to be as-
certained. Genetic typing of this kind of material is gen-
erally difficult because it may have been kept for several
weeks or months at 4°C. Furthermore, urine from healthy
individuals, especially males, contains very few nucleated
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cells [2, 7, 8] and shelter yeast cells and bacteria that can be
detrimental to the amplification of human DNA [1, 7, 9].
Some urine components such as urea may further inhibit
the PCR reaction [9, 10].
In this study, we wanted to evaluate the potential to
genetically identify male urine samples stored under sub-
optimal conditions. For this purpose, 20 urine samples
were kept for 6, 60 and 120 days at 4°C. DNA was ex-
tracted with both phenol–chloroform (P/C) and silica-based
protocols and analysed with both nDNA (SGM Plus kit)
and mtDNA markers (HVRI and HVRII). These data were
used to evaluate the two DNA extraction protocols as well
as to compare the identification potential of nDNA and
mtDNA markers.
Materials and methods
Sample collection and DNA extraction
Urine (i.e. questioned samples) and blood (i.e. reference
samples) samples were collected from 20 volunteer male
donors of European Caucasian origin. Women were not
considered in this study because female urine contains
more DNA and is therefore easier to genotype [2, 7, 8].
Each urine sample was divided into 3×25-ml aliquots that
were immediately stored at 4°C. DNA was extracted from
these samples after 6, 60 and 120 days. The 25-ml aliquots
corresponding to the first two storage periods were cen-
trifuged for about 40 min at 4,000 rpm to obtain pellet
volumes of around 250 μl. In order to maximize the re-
covery of cellular material, samples from the last period
were concentrated with a Centricon Plus-20 (Millipore AG,
Volketswil, Switzerland), following the manufacturer’s in-
structions. The resulting pellets or concentrates were di-
vided into two equal parts; one part was extracted with a
P/C protocol [11] and the other one with the QIAamp viral
RNA Mini Kit (Qiagen AG, Basel, Switzerland), follow-
ing the manufacturer’s recommendations. This latter kit
co-extracts viral RNA and cellular DNA from body fluids
and is suitable for the genotyping of urine samples [12].
Blood samples were stored at −20°C until they were ex-
tracted with the QIAamp DNA Mini Kit according to the
manufacturer’s instructions. All DNA extracts were con-
centrated by membrane-based size exclusion with Micro-
con 30 spin columns (Millipore) in order to get 20–25 μl
final volume. Genomic DNA was quantified with a dot-
blot method using the Quantiblot system from Applied
Biosystems.
Nuclear STRs amplification and mtDNA sequencing
Amplification of nDNA was carried out with the
AmpFLSTR SGM Plus Multiplex (Applied Biosystems),
following the manufacturer’s instructions, but in 25-μl
reaction volumes. This kit enables ten STR loci (D3S1358,
VWA, D16S539, D2S1338, D8S1179, D21S11, D18S51,
D19S433, TH01, FGA) and the gender marker Ameloge-
nin to be tested. In order to enhance the sensitivity of the
amplification, extracts that contained less than 200 pg/μl
DNA were amplified with 34 PCR cycles using a multi-
tube approach [13]. The amplicons were run on an ABI 310
Genetic Analyzer and sized with the internal lane standard
and allelic ladder using the Genescan and Genotyper
softwares (Applied Biosystems). Profiles obtained with
34 PCR cycles were scored following the guidelines
from [13].
The two hypervariable domains of the mitochondrial
control regions HVI and HVII were amplified with the pair
of primers L15896:CAAATGGGCCTGTCCTTGTA/H
16414:TGTGCGGGATATTGATTTC (O. Froment, perso-
nal communication) and L00029:GGTCTATCACCCTAT
TAACCAC/H00408:CTGTTAAAAGTGCATACCGCCA
[14], respectively. Amplifications were carried out in 25-μl
reaction volumes with 1 μl template DNA, 0.5 μM of each
primer, 2.5 μl 10× enhancer PCR buffer (Invitrogen AG,
Basel, Switzerland), 2.5 μl PCR enhancer solution (Invi-
trogen), 0.2 mM of each dNTP (Takara; Axon Lab AG,
Baden-Dättwil, Switzerland), 8 μg BSA, 2 mM MgSO4
(Takara) and 0.625 U Ex Taq DNA polymerase hot start
(Takara). The PCR programme consisted of 30 s at 94°C,
30 s at 56°C and 60 s at 72°C over 36 cycles on a GeneAmp
PCR System 9700 (Applied Biosystems). PCR products
were purified with QIAquick PCR purification kits (Qia-
gen), following the manufacturer’s instructions. Sequenc-
ing reactions were performed in 20-μl reaction volumes
using the BigDye Terminator Cycle sequencing kit version
1.1 (Applied Biosystems). After being cleaned with Centri-
sep spin columns, sequencing products were analysed on
an ABI 310 Genetic Analyzer with the sequencing module
Seq POP6 Rapid (1 ml), filter set E. Sequences were
visualized and edited with the softwares Data Collection,
Sequence Analysis, Sequence navigator and Factura from
Applied Biosystems.
Statistical analysis
The two DNA extraction protocols were compared ac-
cording to the concentrations of DNA recovered and to the
numbers of SGM Plus loci that were successfully scored
after amplification. The significance of these comparisons
was evaluated with Wilcoxon’s rank tests. An LR was used
to quantify the strength of a match between a urine sample
and the corresponding blood sample. LRs per locus were
calculated using the formula of Balding and Nichols [15],
using θ=0.01 to represent the level of co-ancestry within
the Caucasian population [16]. Individual LRs were mul-
tiplied across loci. The LR for the mtDNA marker was
estimated, taking into account the number of observations
of the haplotype i in a database of n haplotypes corrected
for sampling errors [15]. The nDNA allele frequencies
were taken from [17, 18]. European Caucasian mtDNA
sequences were extracted from [19–23], as well as from a
data base from our own laboratory. Information gathered at
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these two kinds of genetic markers was considered as
independent. This implied that nDNA and mtDNA LRs
could be multiplied to estimate overall LRs.
Results
DNA concentrations and DNA typing
The amounts of nDNA recovered with the two extraction
protocols dramatically decreased over the 4-month period
(Fig. 1). The detection threshold of the dot-blot method
used to estimate DNA concentrations was around 30 pg/μl
because the band of the standard corresponding to this
concentration was always detected. Important quantitative
differences were observed between the two extraction
protocols. After 6 and 60 days, about four times more
nDNAwas recovered with P/C compared to the Qiagen kit
(Fig. 1). After 120 days, variable amounts of DNA were
detected in 50% of the samples extracted with the P/C
protocol, whereas a complete absence of signal on the dot-
blot characterized all samples extracted with the Qiagen kit
(Fig. 1). The differences observed between the two treat-
ments were highly significant for the three periods
considered (P<0.005; Wilcoxon’s rank tests). Comparable
numbers of loci were obtained for urine samples with both
extraction protocols (Fig. 2), and no significant differences
were detected, whatever the period considered (P>0.050;
Wilcoxon’s rank tests). However, PCR conditions used to
amplify the nDNA varied between treatments. Of the 60
extracts obtained with the P/C and Qiagen extraction
procedures, 37 and 17%, respectively, contained at least
200 pg/μl DNA and were amplified with standard PCR
conditions. Remaining samples were considered as low
copy number (LCN) and amplified between three and six
times with 34 PCR cycles. Despite the occurrence of allelic
drop-out and false alleles associated with LCN analysis, all
nDNA profiles obtained from urine samples perfectly
matched those of reference samples.
Selective sequencing of samples for which less than four
nDNA loci could be scored were conducted. Sequences of
the HVI and HVII regions were obtained for 100% of the
17 samples matching this criterion, whatever the extraction
protocol used and the period considered. The 17 urine
mtDNA haplotypes were identical to those of the 12 cor-
responding reference samples (Table 1).
Sample identification
Likelihood ratios were estimated only for samples treated
with the P/C extraction protocol because it significantly
improved the recovery of DNA from urine samples
(Fig. 1). Overall, nDNA LRs greater than 1,000,000 char-
acterized nDNA profiles having between five and ten loci
(Table 1). Values comprised between 6,073 and 47,390
were associated with profiles having three to four loci.
Finally, nDNA LRs from 37 to 278 were calculated for
profiles with one locus and two loci. With only one locus,
an nDNA LR of 160 was obtained for the sample U3 after 4
months (Table 1). This sample was homozygous for the
allele 16 at the locus D19S433. This rare allele has a
frequency of 0.056 in the Swiss reference population.
Conversely, two loci were scored for the sample U16 after
4 months, but the nDNA LR was only 61. Indeed, the
genotype of this sample was 13–14 at the D19S433 locus
and 9–9.3 at the THO1 locus. This genotype is common
because the frequencies of the corresponding alleles are all
between 0.144 and 0.350.
The 12 mtDNA LRs estimated for the 17 samples with
less than four nDNA loci are given in Table 1. They varied
from 43, for the most common haplotype, to 435, for
haplotypes that were not observed in the available database
of 867 European Caucasian sequences. When the genetic
information from nDNA and mtDNA markers was com-
bined, overall LRs were between 290 (sample U19 after
120 days) and more than two million (samples U3 after 6
days and U10 after 120 days).
Discussion
Many substances such as illicit drugs or doping products
are excreted by the kidneys and can be detected in urine.
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Fig. 1 Average DNA concentrations of 20 urine samples stored at
4°C for 6, 60 and 120 days. DNAwas extracted with a P/C protocol
and the QIAamp viral RNA Mini Kit (QIA). Vertical bars represent
standard deviations. Differences were highly significant for the three
periods (P<0.005; Wilcoxon’s rank tests)
0
2
4
6
8
10
12
6 days 60 days 120 days
Storage period at 4ºC
n
u
m
be
r o
f l
oc
i
PC
QIA
NS 
NS 
NS 
Fig. 2 Same as Fig. 1, but for the mean numbers of reliable SGM
Plus loci (without Amelogenin). None of the three comparisons was
significant (P>0.050; Wilcoxon’s rank tests)
69
Since they are easy to collect, urine samples are often used
in clinical, toxicological or doping control tests. These
samples can be subject to accidental mixing or intentional
manipulations. It is therefore of prime interest to provide a
way to ascertain identity. In this study, we used a controlled
storage experiment in order to evaluate the potential of
identifying urine samples from European Caucasian vol-
unteers using nDNA and mtDNA markers.
Several factors may influence the genetic identification
process. A major one is the amount of DNA that can be
recovered from samples. This amount mainly depends on
the nature of the sample considered, the storage conditions
and the efficiency of the protocol used to extract DNA.
Urine generally contains small numbers of nucleated cells
and is thus difficult to genotype [e.g. 1, 2, 6–10]. Moreover,
the 20 samples tested in this work were stored at 4°C over a
4-month storage period, which can be detrimental for the
few DNA they contain. Accordingly, both DNA concen-
trations and numbers of loci scored for the SGM Plus
profiles decreased over time for most of the samples
(Figs. 1 and 2). Some of them were apparently not con-
cerned with this trend. More loci were scored for urines U3,
U17 and U20 after 120 than after 60 days (Table 1). The
same phenomenon was observed when these samples were
extracted with the silica-based protocol (results not shown).
This peculiarity may result from the concentration step of
urine that preceded the DNA extraction. It is likely that the
centrifuge filters (Centricon Plus-20) used after 4 months
were more efficient to concentrate the samples than the
centrifugation alone used after 2 months (see Materials and
methods). It is also possible that centrifuge filters removed
bacteria or fungi whose DNA may inhibit the amplification
of human DNA [7]. Concerning the choice of the DNA
extraction protocol, it is worth mentioning that about four
times more nDNAwas recovered from urine samples when
using a P/C protocol rather than a silica-based extraction
method (Fig. 1). Interestingly, the use of increased number
of PCR-cycles [24] together with a multi-tube approach
[13] apparently allowed to compensate for this difference
because similar numbers of loci were scored for the nDNA
profiles obtained with both extraction protocols (Fig. 2).
Another important factor that influences the identifica-
tion process is the choice of the genetic marker. In this
study, nDNA LRs were generally high, but decreased with
increasing storage period (Table 1). Conversely, mtDNA
LRs were generally low, but did not change over time. In
fact, sequences of the HVI and HVII regions could be
obtained for all the samples tested, whatever the period
considered. From a practical point of view, the establish-
ment of one nDNA profile requires one PCR reaction with
a commercial kit containing multiplexed loci. In contrast, at
least two amplifications and two sequencing reactions (i.e.
a minimum of four PCR reactions) are needed to obtain
HVI and HVII sequences for a single individual. Note that
some laboratories may use up to eight or more PCRs to
amplify and sequence the entire control region [e.g. 25].
The number of PCRs needed to obtain a single nDNA or
mtDNA profile has to be further increased because genetic
Table 1 Numbers of loci successfully scored (loci) and nDNA LRs for urine samples (U1–20) analysed after the three storage periods
Urine sample 6 days at 4°C 60 days at 4°C 120 days at 4°C 6–120 days at 4°C
Loci nDNA LRs Loci nDNA LRs Loci nDNA LRs mtDNA LRs
U1 10 2.1E+12 0 1 0 1 435 (0)
U2 10 4.2E+12 5 7.1E+05 0 1 435 (0)
U3 3 6073 0 1 1 160 435 (0)
U4 10 4.3E+12 10 4.3E+12 7 8.2E+09 NS
U5 10 7.4E+10 8 2.4E+08 4 7086 NS
U6 10 2.0E+14 10 2.0E+14 10 2.0E+14 NS
U7 10 1.5E+12 6 3.0E+07 4 1.2E+04 NS
U8 10 1.9E+13 10 1.9E+13 7 1.1E+08 NS
U9 10 3.0E+11 10 3.0E+11 5 3.7E+05 NS
U10 10 1.2E+13 10 1.2E+13 3 6116 435 (0)
U11 10 9.1E+10 8 5.6E+08 2 278 87 (8)
U12 10 1.3E+14 2 222 0 1 435 (0)
U13 10 1.0E+13 7 3.4E+09 0 1 435 (0)
U14 10 7.6E+13 10 7.6E+13 10 7.6E+13 NS
U15 10 5.4E+15 9 9.5E+13 7 2.0E+11 NS
U16 9 2.1E+09 6 3.9E+05 2 61 43 (18)
U17 10 1.9E+13 0 1 4 2.5E+04 435 (0)
U18 10 2.8E+16 1 37 0 1 435 (0)
U19 10 2.0E+13 5 1.2E+07 0 1 290 (1)
U20 10 2.1E+11 0 1 4 4.7E+04 435 (0)
Samples with underlined numbers of loci were amplified with 28 instead of 34 PCR cycles. The 17 samples with less than four loci were
analysed for the mtDNA HVI and HVII regions. The 12 corresponding mtDNA LRs were estimated according to the number of
observations (in brackets) of each haplotype in a database of 867 sequences
NS Not sequenced
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profiles should be at least duplicated [13, 26, 27] and the
analyses monitored with several negative and positive
controls [e.g. 27]. More efforts are also needed to read and
edit several hundreds of nucleotides from the mtDNA
hypervariable regions, compared to reading 10 to 15 loci
for the nDNA markers. The actual doubts concerning the
reliability of mtDNA databases reflect the complexity of
analysing this haploid marker. In fact, sequencing and
reporting errors, as well as artificial recombination between
several regions from different samples, were documented
in several data sets [e.g. 28, 29]. When dealing with
samples from doping control cases or crime scenes, the
occurrence of “artificial sequences” is likely to result in
false exclusions. In case of inclusions, the maximal value
of mtDNA LRs would be overestimated because the oc-
currence of artificial sequences would increase the size of
the data base. In other words, this would give more support
to the hypothesis that the sample originated from the
suspect rather than from someone else from the reference
population. In the present study, the maximum LR was 435
for a data base of 867 European Caucasian haplotypes. It
would have been 5,001 for a data base containing 10,000
sequences. According to the results presented in Table 1,
nDNA LRs obtained with only three loci can easily exceed
this value. The exclusion power of mtDNA markers can be
greatly enhanced by using polymorphism located outside
the HVI and HVII regions [e.g. 30, 31]. Nevertheless, the
strength of a match between two samples (i.e. the inclusion
power) would not change until this extra information is
integrated in huge extended error-free databases. It thus
seems more strategic to systematically analyse biological
samples that are poor in nucleated cells and/or that were
stored in bad conditions with nDNA markers before under-
taking mtDNA analyses. Within this context, nDNA STRs
with reduced-size amplicons and/or LCN approaches could
help recover some loci for difficult samples [e.g. 32, 33].
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